Voyager Therapeutics
This company is dedicated to breaking through barriers in gene therapy and neurology. Learn more
Launch date
Employees
Market cap
AUD527m
Enterprise valuation
AUD26m (Public information from Sep 2024)
Share price
$6.32 VYGR
Cambridge Massachusetts (HQ)
Authorizing premium user...